During the past decade, Ryazan Regional Clinincal Cardiology Dispensary conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ryazan Regional Clinincal Cardiology Dispensary" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ryazan Regional Clinincal Cardiology Dispensary" are "Rheumatoid Arthritis" (4 trials), "Asthma" (1 trials), "Axial Spondyloarthritis" (1 trials), "Peripheral Arterial Disease" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Ryazan Regional Clinincal Cardiology Dispensary" in a lesser frequency.

Most popular intervention types in "Ryazan Regional Clinincal Cardiology Dispensary" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Baricitinib" (2 trials), "Etanercept" (1 trials), "Insulin Glargine" (1 trials) and "Ixekizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ryazan Regional Clinincal Cardiology Dispensary" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Ryazan Regional Clinincal Cardiology Dispensary". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Ryazan Regional Clinincal Cardiology Dispensary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ryazan Regional Clinincal Cardiology Dispensary, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Ryazan Regional Clinincal Cardiology Dispensary has several departments that took part in Clinical trials: "GBU of Ryazan region Regional clinical cardiology dispanser" - 4 trials